Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen you compare Wegovy prices in the UK, the honest answer is that private treatment costs vary considerably by dose and provider, typically ranging from roughly £149 to £375 per month across the market. But the headline figure rarely tells the full story. Wegovy is a prescription-only medicine, which means the law requires clinical assessment before a prescriber can authorise it. Any price you see advertised should include that assessment, yet many don't. Understanding what sits behind a quoted number is the practical starting point before you spend anything.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy (semaglutide, made by Novo Nordisk) is a Prescription-Only Medicine. Under UK law, no pharmacy can dispense it without a valid prescription issued after clinical assessment. So before you compare prices for Wegovy at all, the first filter is simple: does the quoted price include a consultation with a qualified prescriber? If it doesn't, either the service is operating outside the law or the consultation fee comes as a surprise later.
You can verify any online pharmacy offering Wegovy on the GPhC register. If a provider doesn't appear there, stop. The MHRA has warned repeatedly about fake weight-loss pens circulating online, some of which have contained insulin rather than the medicine on the label.
The second baseline check is licensing. NICE's appraisal of semaglutide (TA875) outlines the clinical criteria that should inform any responsible prescribing decision. A legitimate provider applies those criteria. One that skips the assessment to offer a lower headline price is cutting the thing that keeps you safe. That's worth factoring into any price comparison before you go further.
A quoted monthly figure for Wegovy often covers the medicine itself and little else. The costs that commonly appear separately include the initial consultation fee, an ongoing prescription charge, delivery (sometimes per order, sometimes tiered by dose), and any aftercare or dose-review support.
The dose matters more than most comparison tables acknowledge. Wegovy's maintenance pathway runs from 0.25mg through to 2.4mg weekly, titrated over roughly four months. The full range of Wegovy prices by dose reflects real differences in medicine cost at each stage, so a price comparison that shows only one figure is usually comparing the cheapest starting-dose pen, not the maintenance dose you'll likely be on for most of your treatment.
Delivery is the detail that catches people out. If you're ordering before 12pm on a weekday and expecting the pen to arrive tomorrow, that's a specific logistical promise. Some providers charge for that. Some use standard post. Worth confirming before you place an order rather than after your pen fails to arrive in time for your usual injection day.
For a rounded view of how semaglutide pricing sits across the market, the Wegovy price comparison page covers this in more detail, including a breakdown of what the 1mg dose costs across UK providers for anyone partway through the titration schedule.
Wegovy's pricing has shifted over time, and not downward. It helps to understand that. You can read more about the background on our page on Wegovy price changes. Private providers set their own margins on top of supply costs, which is why comparing Wegovy prices across UK services produces a spread rather than a single number.
Those reported market figures (roughly £149 to £375 per month) are widely cited but hedged for good reason: they shift with dose, demand and individual provider decisions. The 2.4mg maintenance dose comparison gives the clearest like-for-like picture, since 2.4mg is where most people on Wegovy eventually end up.
There's also the question of what happens when your dose increases. Some providers review pricing at each step without informing patients upfront. A transparent all-in price per dose pen, stated clearly before you commit, is the thing to look for. If a provider's pricing page requires you to work backwards from a bundle or add up components, that's useful information about how they'll communicate with you as a patient, not just as a customer.
At nume, we don't compete on being the lowest price. That's a deliberate position, not a gap in our offer. The single price on our treatment page covers consultation, prescription, medicine, next-working-day DPD delivery and ongoing clinical aftercare. A named prescriber, not software, reads your consultation the same day. There are no subscriptions and no auto-renewals; each repeat is clinically re-reviewed.
Cheapest isn't the right test for a prescription medicine. The question is whether you're getting genuine medicine from a pharmacy you can verify, assessed by a qualified clinician, with someone to call if something doesn't feel right. Those are the things worth comparing. Our clinical team and our lead prescriber's profile are there to read if you want to know who is reviewing your case.
If you want to compare semaglutide against other treatment options, the semaglutide price comparison page covers the broader picture, including how Wegovy sits alongside other licensed weight-loss treatments. Our weight-loss treatment overview is a good starting point if you're still weighing up which medicine might suit you. For everything else, our FAQs cover the questions we hear most often.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.